Drugs / LUCAR-DKS1 NK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07095075 | Oct 2025 → Dec 2029 expected | — | Nanjing Legend Biotech Co. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUCAR-DKS1 NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07095075 ↗ |
| Modality | Cell therapy | “a chimeric antigen receptor (CAR) -NK cell therapy” NCT07095075 ↗ |